Literature DB >> 1671787

Serum non-organ specific autoantibodies in human immunodeficiency virus 1 infection.

F Cassani1, L Baffoni, E Raise, L Selleri, M Monti, L Bonazzi, F M Gritti, F B Bianchi.   

Abstract

Serum samples from 66 seropositive subjects (56 with a history of intravenous drug abuse), including asymptomatic carriers and patients with persistent generalised lymphadenopathy (PGL), AIDS related complex (ARC), and AIDS, were tested by indirect immunofluorescence on rat tissue sections and HEp-2 cells for the presence of antibodies to nuclei, smooth muscle, intermediate filaments (anti-IMF) and microfilaments (anti-MF). Counterimmunoelectrophoresis was also used to detect antibodies to extractable nuclear antigens. Smooth muscle antibodies with the V pattern or antinuclear antibodies, mainly of the speckled type, or anti-IMF, occurred in 35 cases, being widely distributed in all groups. Such an autoantibody response resembles the "viral" autoimmunity described in various infectious diseases and in particular that of non-A, non-B post-transfusion hepatitis. Autoantibodies may be of some prognostic relevance, as the prevalence of smooth muscle antibodies V increased as the disease progressed (asymptomatic carriers 20%, those with PGL 29%, those with ARC 47%, and those with AIDS 63%. In the PGL group autoantibody positivity correlated with the presence of skin anergy. The fact that autoantibodies were more frequently detected in patients with circulating immune complexes suggests that these can contain autoantibodies and the corresponding autoantigens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671787      PMCID: PMC497018          DOI: 10.1136/jcp.44.1.64

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  33 in total

1.  Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin.

Authors:  C Brown; J Pedersen; J R Underwood; I Gust; B H Toh
Journal:  J Clin Lab Immunol       Date:  1986-01

2.  Individuals infected with HIV possess antibodies against IL-2.

Authors:  K L Bost; B H Hahn; M S Saag; G M Shaw; D A Weigent; J E Blalock
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

3.  Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals.

Authors:  H Golding; G M Shearer; K Hillman; P Lucas; J Manischewitz; R A Zajac; M Clerici; R E Gress; R N Boswell; B Golding
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

4.  Autoimmunity in chronic liver disease caused by hepatitis delta virus.

Authors:  D Zauli; C Crespi; F B Bianchi; A Craxi; E Pisi
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

5.  All classes of intermediate filaments share a common antigenic determinant defined by a monoclonal antibody.

Authors:  R M Pruss; R Mirsky; M C Raff; R Thorpe; A J Dowding; B H Anderton
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

6.  Classification of smooth muscle autoantibodies detected by immunofluorescence.

Authors:  G F Bottazzo; A Florin-Christensen; A Fairfax; G Swana; D Doniach; U Groeschel-Stewart
Journal:  J Clin Pathol       Date:  1976-05       Impact factor: 3.411

7.  Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus.

Authors:  S M Schnittman; H C Lane; S E Higgins; T Folks; A S Fauci
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

8.  Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.

Authors:  R Yarchoan; R R Redfield; S Broder
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

9.  Immunomorphological characterisation of antinuclear antibodies in chronic liver disease.

Authors:  F Cassani; F B Bianchi; M Lenzi; U Volta; E Pisi
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

10.  An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells.

Authors:  R B Stricker; T M McHugh; D J Moody; W J Morrow; D P Stites; M A Shuman; J A Levy
Journal:  Nature       Date:  1987 Jun 25-Jul 1       Impact factor: 49.962

View more
  1 in total

1.  Nonorgan-specific autoantibodies in HIV-infected patients in the HAART era.

Authors:  Laura Iordache; Djaouida Bengoufa; Olivier Taulera; Agathe Rami; Caroline Lascoux-Combe; Nesrine Day; Maguy Parrinello; Pierre-Olivier Sellier; Jean-Michel Molina; Alfred Mahr
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.